Using inhibitors of AKT and mTOR, we demonstrated that these kinases play crucial roles in endometrial cancer cell survival and without them, sulforaphane can no longer reduce endometrial cancer cell line viability. The gene discussed is AKT1; the disease is endometrial cancer.